nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—CYP2D6—Parkinson's disease	0.375	0.583	CbGaD
Captopril—ABCB1—Parkinson's disease	0.267	0.417	CbGaD
Captopril—REN—forelimb zeugopod—Parkinson's disease	0.0194	0.109	CbGeAlD
Captopril—REN—sympathetic nervous system—Parkinson's disease	0.0141	0.0796	CbGeAlD
Captopril—REN—autonomic nervous system—Parkinson's disease	0.00947	0.0535	CbGeAlD
Captopril—REN—arm—Parkinson's disease	0.00836	0.0473	CbGeAlD
Captopril—ACE—forelimb zeugopod—Parkinson's disease	0.00825	0.0466	CbGeAlD
Captopril—REN—peripheral nervous system—Parkinson's disease	0.00683	0.0386	CbGeAlD
Captopril—F2—forelimb—Parkinson's disease	0.00679	0.0384	CbGeAlD
Captopril—ACE—sympathetic nervous system—Parkinson's disease	0.006	0.0339	CbGeAlD
Captopril—REN—nerve—Parkinson's disease	0.00532	0.0301	CbGeAlD
Captopril—ACE—forelimb—Parkinson's disease	0.00415	0.0234	CbGeAlD
Captopril—ACE—autonomic nervous system—Parkinson's disease	0.00403	0.0228	CbGeAlD
Captopril—REN—hindbrain—Parkinson's disease	0.00399	0.0225	CbGeAlD
Captopril—ACE—arm—Parkinson's disease	0.00356	0.0201	CbGeAlD
Captopril—LTA4H—embryo—Parkinson's disease	0.00323	0.0183	CbGeAlD
Captopril—ACE—peripheral nervous system—Parkinson's disease	0.00291	0.0165	CbGeAlD
Captopril—LTA4H—forebrain—Parkinson's disease	0.00286	0.0162	CbGeAlD
Captopril—LTA4H—cardiovascular system—Parkinson's disease	0.00242	0.0137	CbGeAlD
Captopril—MMP2—embryo—Parkinson's disease	0.00229	0.013	CbGeAlD
Captopril—REN—brainstem—Parkinson's disease	0.00229	0.0129	CbGeAlD
Captopril—ACE—nerve—Parkinson's disease	0.00227	0.0128	CbGeAlD
Captopril—REN—forebrain—Parkinson's disease	0.00221	0.0125	CbGeAlD
Captopril—LTA4H—medulla oblongata—Parkinson's disease	0.00206	0.0117	CbGeAlD
Captopril—MMP9—embryo—Parkinson's disease	0.00199	0.0113	CbGeAlD
Captopril—LTA4H—midbrain—Parkinson's disease	0.00189	0.0107	CbGeAlD
Captopril—REN—cardiovascular system—Parkinson's disease	0.00187	0.0105	CbGeAlD
Captopril—LTA4H—spinal cord—Parkinson's disease	0.00184	0.0104	CbGeAlD
Captopril—MMP2—cardiovascular system—Parkinson's disease	0.00171	0.00969	CbGeAlD
Captopril—LTA4H—head—Parkinson's disease	0.00164	0.00925	CbGeAlD
Captopril—LTA4H—nervous system—Parkinson's disease	0.00155	0.00877	CbGeAlD
Captopril—LTA4H—central nervous system—Parkinson's disease	0.00149	0.00845	CbGeAlD
Captopril—MMP9—cardiovascular system—Parkinson's disease	0.00149	0.00843	CbGeAlD
Captopril—MMP2—medulla oblongata—Parkinson's disease	0.00146	0.00828	CbGeAlD
Captopril—LTA4H—cerebellum—Parkinson's disease	0.00146	0.00825	CbGeAlD
Captopril—MMP2—midbrain—Parkinson's disease	0.00134	0.00757	CbGeAlD
Captopril—MMP2—spinal cord—Parkinson's disease	0.00131	0.00739	CbGeAlD
Captopril—F2—cardiovascular system—Parkinson's disease	0.0013	0.00736	CbGeAlD
Captopril—REN—head—Parkinson's disease	0.00126	0.00714	CbGeAlD
Captopril—REN—nervous system—Parkinson's disease	0.0012	0.00677	CbGeAlD
Captopril—LTA4H—brain—Parkinson's disease	0.00119	0.0067	CbGeAlD
Captopril—MMP2—head—Parkinson's disease	0.00116	0.00656	CbGeAlD
Captopril—REN—central nervous system—Parkinson's disease	0.00115	0.00652	CbGeAlD
Captopril—MMP9—spinal cord—Parkinson's disease	0.00114	0.00642	CbGeAlD
Captopril—REN—cerebellum—Parkinson's disease	0.00113	0.00637	CbGeAlD
Captopril—MMP2—nervous system—Parkinson's disease	0.0011	0.00622	CbGeAlD
Captopril—ACE—embryo—Parkinson's disease	0.00106	0.00601	CbGeAlD
Captopril—MMP2—central nervous system—Parkinson's disease	0.00106	0.00599	CbGeAlD
Captopril—MMP9—head—Parkinson's disease	0.00101	0.00571	CbGeAlD
Captopril—F2—spinal cord—Parkinson's disease	0.000991	0.00561	CbGeAlD
Captopril—MMP9—nervous system—Parkinson's disease	0.000957	0.00541	CbGeAlD
Captopril—ACE—forebrain—Parkinson's disease	0.00094	0.00531	CbGeAlD
Captopril—MMP9—central nervous system—Parkinson's disease	0.000922	0.00521	CbGeAlD
Captopril—REN—brain—Parkinson's disease	0.000915	0.00518	CbGeAlD
Captopril—F2—head—Parkinson's disease	0.000881	0.00498	CbGeAlD
Captopril—MMP2—brain—Parkinson's disease	0.000841	0.00476	CbGeAlD
Captopril—F2—nervous system—Parkinson's disease	0.000835	0.00472	CbGeAlD
Captopril—CYP2D6—hindbrain—Parkinson's disease	0.000832	0.0047	CbGeAlD
Captopril—F2—central nervous system—Parkinson's disease	0.000804	0.00455	CbGeAlD
Captopril—ACE—cardiovascular system—Parkinson's disease	0.000795	0.00449	CbGeAlD
Captopril—MMP9—brain—Parkinson's disease	0.000732	0.00414	CbGeAlD
Captopril—SLC22A6—brain—Parkinson's disease	0.000654	0.0037	CbGeAlD
Captopril—F2—brain—Parkinson's disease	0.000638	0.00361	CbGeAlD
Captopril—ACE—spinal cord—Parkinson's disease	0.000606	0.00342	CbGeAlD
Captopril—ACE—head—Parkinson's disease	0.000538	0.00304	CbGeAlD
Captopril—ACE—nervous system—Parkinson's disease	0.00051	0.00289	CbGeAlD
Captopril—ACE—central nervous system—Parkinson's disease	0.000491	0.00278	CbGeAlD
Captopril—CYP2D6—brainstem—Parkinson's disease	0.000477	0.00269	CbGeAlD
Captopril—CYP2D6—forebrain—Parkinson's disease	0.00046	0.0026	CbGeAlD
Captopril—ALB—brain—Parkinson's disease	0.000407	0.0023	CbGeAlD
Captopril—ACE—brain—Parkinson's disease	0.00039	0.00221	CbGeAlD
Captopril—ABCB1—embryo—Parkinson's disease	0.000374	0.00212	CbGeAlD
Captopril—ABCB1—forebrain—Parkinson's disease	0.000331	0.00187	CbGeAlD
Captopril—ABCB1—cardiovascular system—Parkinson's disease	0.00028	0.00158	CbGeAlD
Captopril—CYP2D6—head—Parkinson's disease	0.000263	0.00149	CbGeAlD
Captopril—CYP2D6—nervous system—Parkinson's disease	0.00025	0.00141	CbGeAlD
Captopril—CYP2D6—central nervous system—Parkinson's disease	0.00024	0.00136	CbGeAlD
Captopril—ABCB1—medulla oblongata—Parkinson's disease	0.000239	0.00135	CbGeAlD
Captopril—CYP2D6—cerebellum—Parkinson's disease	0.000235	0.00133	CbGeAlD
Captopril—ABCB1—midbrain—Parkinson's disease	0.000218	0.00124	CbGeAlD
Captopril—ABCB1—spinal cord—Parkinson's disease	0.000213	0.00121	CbGeAlD
Captopril—CYP2D6—brain—Parkinson's disease	0.000191	0.00108	CbGeAlD
Captopril—ABCB1—head—Parkinson's disease	0.000189	0.00107	CbGeAlD
Captopril—ABCB1—nervous system—Parkinson's disease	0.00018	0.00102	CbGeAlD
Captopril—ABCB1—central nervous system—Parkinson's disease	0.000173	0.000978	CbGeAlD
Captopril—ABCB1—cerebellum—Parkinson's disease	0.000169	0.000956	CbGeAlD
Captopril—ABCB1—brain—Parkinson's disease	0.000137	0.000776	CbGeAlD
Captopril—ALB—SLC-mediated transmembrane transport—CP—Parkinson's disease	8.48e-05	0.000468	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—CP—Parkinson's disease	8.29e-05	0.000458	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GRM5—Parkinson's disease	8.08e-05	0.000446	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	8.04e-05	0.000444	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PPP1R1B—Parkinson's disease	7.97e-05	0.00044	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.96e-05	0.00044	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—CASP3—Parkinson's disease	7.93e-05	0.000438	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	7.89e-05	0.000436	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—EDN1—Parkinson's disease	7.87e-05	0.000434	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—INS—Parkinson's disease	7.86e-05	0.000434	CbGpPWpGaD
Captopril—F2—Hemostasis—SOD1—Parkinson's disease	7.75e-05	0.000428	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	7.73e-05	0.000427	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	7.73e-05	0.000427	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—IL6—Parkinson's disease	7.69e-05	0.000425	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GRM4—Parkinson's disease	7.67e-05	0.000424	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.64e-05	0.000422	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—INS—Parkinson's disease	7.59e-05	0.000419	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—ADORA2A—Parkinson's disease	7.57e-05	0.000418	CbGpPWpGaD
Captopril—F2—Hemostasis—ABL1—Parkinson's disease	7.4e-05	0.000408	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL1B—Parkinson's disease	7.38e-05	0.000408	CbGpPWpGaD
Captopril—F2—Hemostasis—IGF2—Parkinson's disease	7.36e-05	0.000407	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PENK—Parkinson's disease	7.27e-05	0.000401	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAG—Parkinson's disease	7.27e-05	0.000401	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	7.13e-05	0.000394	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.03e-05	0.000388	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RIT2—Parkinson's disease	6.96e-05	0.000385	CbGpPWpGaD
Captopril—F2—Hemostasis—HGF—Parkinson's disease	6.95e-05	0.000384	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—HTR2A—Parkinson's disease	6.88e-05	0.00038	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—ADORA2A—Parkinson's disease	6.87e-05	0.000379	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—INS—Parkinson's disease	6.83e-05	0.000377	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PDYN—Parkinson's disease	6.65e-05	0.000367	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.64e-05	0.000367	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GRK5—Parkinson's disease	6.6e-05	0.000365	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—TNF—Parkinson's disease	6.58e-05	0.000364	CbGpPWpGaD
Captopril—ALB—Hemostasis—MAG—Parkinson's disease	6.57e-05	0.000363	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—HTR1A—Parkinson's disease	6.57e-05	0.000363	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—TAC1—Parkinson's disease	6.47e-05	0.000357	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—INS—Parkinson's disease	6.45e-05	0.000356	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.38e-05	0.000352	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—DRD1—Parkinson's disease	6.34e-05	0.00035	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GFAP—Parkinson's disease	6.25e-05	0.000345	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GRM5—Parkinson's disease	6.18e-05	0.000341	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—DRD3—Parkinson's disease	6.14e-05	0.000339	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	6.04e-05	0.000334	CbGpPWpGaD
Captopril—MMP2—Axon guidance—IL6—Parkinson's disease	6.02e-05	0.000333	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	5.97e-05	0.00033	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HTR1A—Parkinson's disease	5.96e-05	0.000329	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GRM4—Parkinson's disease	5.92e-05	0.000327	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.91e-05	0.000326	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—COMT—Parkinson's disease	5.91e-05	0.000326	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	5.88e-05	0.000325	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—TAC1—Parkinson's disease	5.87e-05	0.000324	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	5.87e-05	0.000324	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	5.86e-05	0.000324	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	5.82e-05	0.000322	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	5.8e-05	0.00032	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—IGF2—Parkinson's disease	5.79e-05	0.00032	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—DRD1—Parkinson's disease	5.76e-05	0.000318	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.73e-05	0.000317	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.67e-05	0.000313	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	5.67e-05	0.000313	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PENK—Parkinson's disease	5.61e-05	0.00031	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAG—Parkinson's disease	5.61e-05	0.00031	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	5.61e-05	0.00031	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	5.6e-05	0.000309	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	5.59e-05	0.000309	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—DRD3—Parkinson's disease	5.58e-05	0.000308	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—HTR7—Parkinson's disease	5.55e-05	0.000307	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—DRD2—Parkinson's disease	5.55e-05	0.000307	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	5.52e-05	0.000305	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGF20—Parkinson's disease	5.42e-05	0.000299	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	5.4e-05	0.000298	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TNF—Parkinson's disease	5.36e-05	0.000296	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	5.35e-05	0.000296	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TNF—Parkinson's disease	5.33e-05	0.000294	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	5.33e-05	0.000294	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	5.31e-05	0.000293	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ADORA2A—Parkinson's disease	5.26e-05	0.00029	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—ADRBK1—Parkinson's disease	5.21e-05	0.000288	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PDYN—Parkinson's disease	5.13e-05	0.000284	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HTR7—Parkinson's disease	5.04e-05	0.000278	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—DRD2—Parkinson's disease	5.04e-05	0.000278	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.93e-05	0.000272	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.93e-05	0.000272	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	4.9e-05	0.000271	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—INSR—Parkinson's disease	4.85e-05	0.000268	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GFAP—Parkinson's disease	4.83e-05	0.000267	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GRM5—Parkinson's disease	4.77e-05	0.000264	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.73e-05	0.000261	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	4.68e-05	0.000259	CbGpPWpGaD
Captopril—ALB—Metabolism—ND3—Parkinson's disease	4.64e-05	0.000256	CbGpPWpGaD
Captopril—ALB—Metabolism—MCCC1—Parkinson's disease	4.64e-05	0.000256	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGB—Parkinson's disease	4.59e-05	0.000253	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HTR1A—Parkinson's disease	4.56e-05	0.000252	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TAC1—Parkinson's disease	4.49e-05	0.000248	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—EDN1—Parkinson's disease	4.45e-05	0.000246	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—DRD1—Parkinson's disease	4.41e-05	0.000243	CbGpPWpGaD
Captopril—ALB—Metabolism—OMD—Parkinson's disease	4.36e-05	0.000241	CbGpPWpGaD
Captopril—ALB—Metabolism—TALDO1—Parkinson's disease	4.36e-05	0.000241	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL6—Parkinson's disease	4.32e-05	0.000239	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	4.31e-05	0.000238	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—IL6—Parkinson's disease	4.3e-05	0.000237	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—DRD3—Parkinson's disease	4.27e-05	0.000236	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	4.26e-05	0.000235	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4.24e-05	0.000234	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGF20—Parkinson's disease	4.19e-05	0.000231	CbGpPWpGaD
Captopril—ALB—Hemostasis—FGB—Parkinson's disease	4.14e-05	0.000229	CbGpPWpGaD
Captopril—ALB—Metabolism—NDUFB11—Parkinson's disease	4.13e-05	0.000228	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	4.1e-05	0.000227	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—Parkinson's disease	4.07e-05	0.000224	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ND3—Parkinson's disease	4.06e-05	0.000224	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MCCC1—Parkinson's disease	4.06e-05	0.000224	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ADORA2A—Parkinson's disease	4.06e-05	0.000224	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EDN1—Parkinson's disease	4.04e-05	0.000223	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ADRBK1—Parkinson's disease	3.98e-05	0.00022	CbGpPWpGaD
Captopril—MMP9—Axon guidance—IL6—Parkinson's disease	3.95e-05	0.000218	CbGpPWpGaD
Captopril—ALB—Metabolism—GCH1—Parkinson's disease	3.94e-05	0.000218	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—HTR2A—Parkinson's disease	3.89e-05	0.000215	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HTR7—Parkinson's disease	3.86e-05	0.000213	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—DRD2—Parkinson's disease	3.86e-05	0.000213	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—INS—Parkinson's disease	3.85e-05	0.000212	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MCCC1—Parkinson's disease	3.83e-05	0.000211	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ND3—Parkinson's disease	3.83e-05	0.000211	CbGpPWpGaD
Captopril—ABCB1—Metabolism—OMD—Parkinson's disease	3.82e-05	0.000211	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TALDO1—Parkinson's disease	3.82e-05	0.000211	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	3.78e-05	0.000209	CbGpPWpGaD
Captopril—F2—Signaling Pathways—INSR—Parkinson's disease	3.75e-05	0.000207	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NDUFB11—Parkinson's disease	3.62e-05	0.0002	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TALDO1—Parkinson's disease	3.6e-05	0.000199	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—OMD—Parkinson's disease	3.6e-05	0.000199	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.56e-05	0.000196	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGB—Parkinson's disease	3.54e-05	0.000195	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HTR2A—Parkinson's disease	3.53e-05	0.000195	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HTR1A—Parkinson's disease	3.52e-05	0.000194	CbGpPWpGaD
Captopril—ALB—Metabolism—FBP1—Parkinson's disease	3.52e-05	0.000194	CbGpPWpGaD
Captopril—ALB—Metabolism—DBH—Parkinson's disease	3.52e-05	0.000194	CbGpPWpGaD
Captopril—ALB—Metabolism—GBA—Parkinson's disease	3.52e-05	0.000194	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—Parkinson's disease	3.49e-05	0.000193	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TAC1—Parkinson's disease	3.47e-05	0.000192	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GCH1—Parkinson's disease	3.46e-05	0.000191	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	3.43e-05	0.00019	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	3.41e-05	0.000188	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DRD1—Parkinson's disease	3.4e-05	0.000188	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DRD3—Parkinson's disease	3.29e-05	0.000182	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GCH1—Parkinson's disease	3.26e-05	0.00018	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF2—Parkinson's disease	3.23e-05	0.000179	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF1R—Parkinson's disease	3.13e-05	0.000173	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EDN1—Parkinson's disease	3.09e-05	0.000171	CbGpPWpGaD
Captopril—ABCB1—Metabolism—DBH—Parkinson's disease	3.08e-05	0.00017	CbGpPWpGaD
Captopril—ABCB1—Metabolism—FBP1—Parkinson's disease	3.08e-05	0.00017	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GBA—Parkinson's disease	3.08e-05	0.00017	CbGpPWpGaD
Captopril—ALB—Hemostasis—SOD1—Parkinson's disease	3.08e-05	0.00017	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ADRBK1—Parkinson's disease	3.08e-05	0.00017	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.07e-05	0.00017	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HTR7—Parkinson's disease	2.98e-05	0.000164	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DRD2—Parkinson's disease	2.98e-05	0.000164	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.95e-05	0.000163	CbGpPWpGaD
Captopril—ALB—Hemostasis—ABL1—Parkinson's disease	2.93e-05	0.000162	CbGpPWpGaD
Captopril—ALB—Hemostasis—IGF2—Parkinson's disease	2.92e-05	0.000161	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GBA—Parkinson's disease	2.9e-05	0.00016	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—DBH—Parkinson's disease	2.9e-05	0.00016	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.9e-05	0.00016	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NGF—Parkinson's disease	2.84e-05	0.000157	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6—Parkinson's disease	2.82e-05	0.000156	CbGpPWpGaD
Captopril—ALB—Hemostasis—HGF—Parkinson's disease	2.76e-05	0.000152	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	2.76e-05	0.000152	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HTR2A—Parkinson's disease	2.7e-05	0.000149	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.69e-05	0.000149	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.58e-05	0.000143	CbGpPWpGaD
Captopril—ALB—Metabolism—DDC—Parkinson's disease	2.58e-05	0.000142	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.56e-05	0.000142	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	2.54e-05	0.00014	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APOE—Parkinson's disease	2.51e-05	0.000139	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF2—Parkinson's disease	2.5e-05	0.000138	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.46e-05	0.000136	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTA4—Parkinson's disease	2.44e-05	0.000135	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF1R—Parkinson's disease	2.41e-05	0.000133	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.41e-05	0.000133	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EDN1—Parkinson's disease	2.39e-05	0.000132	CbGpPWpGaD
Captopril—ABCB1—Metabolism—DDC—Parkinson's disease	2.26e-05	0.000125	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.25e-05	0.000124	CbGpPWpGaD
Captopril—ALB—Metabolism—PLA2G6—Parkinson's disease	2.19e-05	0.000121	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NGF—Parkinson's disease	2.19e-05	0.000121	CbGpPWpGaD
Captopril—ALB—Metabolism—MAOB—Parkinson's disease	2.17e-05	0.00012	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—INS—Parkinson's disease	2.15e-05	0.000119	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTA4—Parkinson's disease	2.13e-05	0.000118	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—DDC—Parkinson's disease	2.13e-05	0.000118	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HTR2A—Parkinson's disease	2.09e-05	0.000115	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.07e-05	0.000114	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.01e-05	0.000111	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.01e-05	0.000111	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APOE—Parkinson's disease	1.94e-05	0.000107	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.92e-05	0.000106	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MAOB—Parkinson's disease	1.9e-05	0.000105	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.81e-05	0.0001	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.79e-05	9.9e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—INS—Parkinson's disease	1.66e-05	9.15e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP2D6—Parkinson's disease	1.61e-05	8.91e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CASP3—Parkinson's disease	1.6e-05	8.82e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CTGF—Parkinson's disease	1.58e-05	8.75e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP2E1—Parkinson's disease	1.48e-05	8.15e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK8—Parkinson's disease	1.47e-05	8.11e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NQO1—Parkinson's disease	1.46e-05	8.06e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—TH—Parkinson's disease	1.44e-05	7.94e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.41e-05	7.81e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CTGF—Parkinson's disease	1.39e-05	7.66e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYCS—Parkinson's disease	1.38e-05	7.63e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.31e-05	7.22e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.29e-05	7.14e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NQO1—Parkinson's disease	1.28e-05	7.06e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TH—Parkinson's disease	1.26e-05	6.96e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CASP3—Parkinson's disease	1.23e-05	6.81e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—Parkinson's disease	1.23e-05	6.77e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—COMT—Parkinson's disease	1.22e-05	6.75e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.22e-05	6.73e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTP1—Parkinson's disease	1.22e-05	6.72e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—MAOA—Parkinson's disease	1.21e-05	6.71e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYCS—Parkinson's disease	1.21e-05	6.68e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.21e-05	6.65e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HMOX1—Parkinson's disease	1.2e-05	6.63e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TH—Parkinson's disease	1.19e-05	6.56e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCB1—Parkinson's disease	1.15e-05	6.36e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.14e-05	6.3e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK8—Parkinson's disease	1.13e-05	6.26e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTM1—Parkinson's disease	1.12e-05	6.18e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—COMT—Parkinson's disease	1.07e-05	5.92e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GPX1—Parkinson's disease	1.07e-05	5.92e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.07e-05	5.89e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MAOA—Parkinson's disease	1.06e-05	5.88e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.05e-05	5.81e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—COMT—Parkinson's disease	1.01e-05	5.58e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.01e-05	5.55e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MAOA—Parkinson's disease	1e-05	5.54e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HMOX1—Parkinson's disease	9.91e-06	5.47e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—MTHFR—Parkinson's disease	9.89e-06	5.46e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTM1—Parkinson's disease	9.8e-06	5.41e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCB1—Parkinson's disease	9.52e-06	5.25e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GPX1—Parkinson's disease	9.39e-06	5.18e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—Parkinson's disease	9.38e-06	5.18e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTM1—Parkinson's disease	9.24e-06	5.1e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOE—Parkinson's disease	9.2e-06	5.08e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GPX1—Parkinson's disease	8.85e-06	4.88e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTHFR—Parkinson's disease	8.66e-06	4.78e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTHFR—Parkinson's disease	8.16e-06	4.51e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOE—Parkinson's disease	8.07e-06	4.45e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—INS—Parkinson's disease	7.86e-06	4.34e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOE—Parkinson's disease	7.6e-06	4.2e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—Parkinson's disease	7.24e-06	4e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—INS—Parkinson's disease	6.89e-06	3.8e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—INS—Parkinson's disease	6.49e-06	3.59e-05	CbGpPWpGaD
